subject area of
- Activation of T lymphocytes for the adoptive immunotherapy of cancer Journal Articles
- Adoptive Cell Therapy Using In Vitro Generated Human CD4+CD25+ Regulatory T Cells With Indirect Allospecificity to Promote Donor-Specific Transplantation Tolerance Journal Articles
- Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes Journal Articles
- Assessing the Safety of a Cell-Based Immunotherapy for Brain Cancers Using a Humanized Model of Hematopoiesis Journal Articles
- CAR-T cell therapy in developing countries: how long should we wait? Journal Articles
- Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model Journal Articles
- Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment Journal Articles
- Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells Journal Articles
- Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses Journal Articles
- Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma Journal Articles
- Donor leukocyte infusions for multiple myeloma Journal Articles
- Endogenous T cells prevent tumor immune escape following adoptive T cell therapy Journal Articles
- Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells Journal Articles
- Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours Journal Articles
- Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model Journal Articles
- Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy Journal Articles
- Generation and Expansion of Human CD4+CD25+ Regulatory T Cells with Indirect Allospecificity: Potential Reagents to Promote Donor-Specific Transplantation Tolerance Journal Articles
- Going viral with cancer immunotherapy Journal Articles
- HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants Journal Articles
- IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells Journal Articles
- Imaging CAR T cell therapy with PSMA-targeted positron emission tomography Journal Articles
- Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Journal Articles
- Immunotherapy-induced CD8+ T Cells Instigate Immune Suppression in the Tumor Journal Articles
- In Vivo Antitumor Efficacy of Tumor-Draining Lymph Node Cells Activated with Nonspecific T-Cell Reagents Journal Articles
- International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma. Journal Articles
- In vitro evaluation of CAR-T cells in patient-derived glioblastoma models Journal Articles
- Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study Journal Articles
- Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment Journal Articles
- Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro Journal Articles
- Prolonged Culture of Vaccine-Primed Lymphocytes Results in Decreased Antitumor Killing and Change in Cytokine Secretion Journal Articles
- Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry. Journal Articles
- Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells Journal Articles
- Reconstitution of Xid Mice with Donor Cells Enriched for CD5+ B Cells Restores Contrasuppressiona Conferences
- Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer Journal Articles
- Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors Journal Articles
- T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice Journal Articles
- T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma Journal Articles
- TGFβ Programs Central Memory Differentiation inEx Vivo–Stimulated Human T Cells Journal Articles
- Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes Journal Articles
- Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells Journal Articles
- The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity Journal Articles
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Journal Articles
- Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2 Journal Articles
- Tumor-Targeting Domains for Chimeric Antigen Receptor T Cells Journal Articles
- Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes Journal Articles
- [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity]. Journal Articles